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Autophagy, an intracellular degradation and en-
ergy recycling mechanism, is emerging as an im-
portant regulator of immune responses. However,
the role of autophagy in regulating neutrophil func-
tions is not known. We investigated neutrophil
biology using myeloid-specific autophagy-deficient
mice and found that autophagy deficiency re-
duced neutrophil degranulation in vitro and in vivo.
Mice with autophagy deficiency showed reduced
severity of several neutrophil-mediated inflammatory
and autoimmune disease models, including PMA-
induced ear inflammation, LPS-induced breakdown
of blood-brain barrier, and experimental autoimmune
encephalomyelitis. NADPH oxidase-mediated reac-
tive oxygen species generation was also reduced
in autophagy-deficient neutrophils, and inhibition of
NADPH oxidase reduced neutrophil degranulation,
suggesting NADPH oxidase to be a player at the
intersection of autophagy and degranulation. Over-
all, this study establishes autophagy as an important
regulator of neutrophil functions and neutrophil-
mediated inflammation in vivo.INTRODUCTION
Neutrophils play a critical role as one of the first lines of innate
immune defense. Activated neutrophils migrate to the site of
inflammation and control microbes by phagocytosis, formation
of neutrophil extracellular traps, and secretion of antimicro-
bials, stored in specialized granular compartments. Neutro-
phils possess at least four types of granules. Among these,
primary, secondary, and tertiary granules develop from the
endoplasmic reticulum (ER)-Golgi network, whereas secretory
vesicles have an endocytic origin (Borregaard, 1997). Primary
(azurophilic) granules contain myeloperoxidase (MPO), b-glucu-
ronidase, elastase, and other antimicrobial factors, whereas
lactoferrin and matrix metalloprotease-9 (MMP-9) are stored
in secondary (specific) granules. Tertiary (gelatinase) granules
also contain MMP-9 but lack lactoferrin. The membranes ofCell Repsecretory vesicles contain several important molecules, in-
cluding b2-integrins (CD11b/CD18) and complement receptors,
which play an essential role in neutrophil migration and activation
(Amulic et al., 2012). Upon activation, these granules are mobi-
lized, fuse with phagosomes or plasma membrane, and release
their contents in the respective environments. Secondary gran-
ules are of interest, as the membranes of these granules contain
flavocytochrome b558, a component of the NADPH oxidase ma-
chinery (Amulic et al., 2012). Thus, fusion of secondary granules
with phagosomes or plasma membrane results in formation of a
functional NADPH oxidase complex, which then produces reac-
tive oxygen species (ROS). Degranulation, a process of regu-
lated exocytosis of granules, is one of the major mechanisms
of inflammatory response by neutrophils. However, the underly-
ing regulatory pathways and their respective roles remain incom-
pletely understood.
Autophagy plays important roles in the immune responses and
abnormalities in this pathway have been linked to several dis-
eases (Levine et al., 2011). More recently, autophagy has been
implicated in regulating secretion (Cadwell et al., 2008; Patel
et al., 2013; Ushio et al., 2011; Bhattacharya et al., 2014b),
though the underlying mechanisms and in vivo relevance are
not fully understood. The role of autophagy in neutrophil func-
tions remains largely unexplored.
Here, we show that deficiency of autophagy reduced degran-
ulation of neutrophils. Autophagy-deficient neutrophils had re-
duced NADPH oxidase-mediated ROS generation. Moreover,
inhibition of NADPH oxidase reduced neutrophil degranulation,
implicating NADPH oxidase in mediating effects of autophagy
on neutrophil degranulation. The in vivo relevance of these find-
ings was shown in the context of autoimmune and inflammatory
processes. These findings establish autophagy as an important
regulator of neutrophil functions and suggest that targeting auto-
phagy pathway could have therapeutic value during infection,
inflammation, or neutrophil-mediated autoimmune diseases.RESULTS
Deficiency of Autophagy Reduced Neutrophil
Degranulation
To evaluate the role of autophagy in neutrophils, we generated
mice with myeloid-specific deletion of Atg7 (called Atg7MD mice
hereafter) by breeding mice bearing floxed Atg7 alleles (Atg7f/forts 12, 1731–1739, September 22, 2015 ª2015 The Authors 1731
Figure 1. ATG7 Deficiency Reduced Neutrophil Degranulation
(A) Representative immunoblot of ATG7 using lysates from purified peritoneal macrophages (PM), bone marrow-derived macrophages (BMDM), spleen-derived
macrophages (SpDM), and bone marrow neutrophils (BMN). Lanes marked f/f and MD denote lysates from control and Atg7MD mice, respectively.
(B) BMN from control or Atg7MD mice were primed with cytochalasin B and then stimulated with 1 mM fMLF for 15 or 30 min. Gelatinase zymography was
performed on supernatants and on lysates from unstimulated BMN; n = 6/group. Densitometry analysis and a representative image, in which each lane or symbol
represents one mouse, are shown.
(C) Lysates from unstimulated BMN, and supernatant collected following cytochalasin B and 1 mM fMLF treatment ofAtg7f/f and Atg7MD neutrophils were used for
immunoblotting by lactoferrin antibody. n = 6–9/group. Each lane or symbol represents one mouse.
(D) BMN from control orAtg7MDmicewere stimulated as above. Supernatant was collected and incubated overnight with p-nitrophenyl-b-D-glucuronide (for b-D-
glucuronidase). OD values were measured at 405 nm.
(E and F) BMN were stimulated with cytochalasin B and 1 mM fMLF, 1 mg/ml LPS, or 1 mg/ml PMA for 15 min and evaluated by flow cytometry using antibodies
against Ly6G and CD11b (E) or LAMP-1 (F). n = 6/group. Each symbol represents one mouse.
Data are mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001. MFI, mean fluorescence intensity.mice) with transgenic LysM-cre mice (Abdel Fattah et al., 2015;
Bonilla et al., 2013; Shin et al., 2013). Bone marrow neutrophils
(BMNs) from Atg7MD mice showed substantial reduction of1732 Cell Reports 12, 1731–1739, September 22, 2015 ª2015 The AATG7, and the efficiency of genetic deletion was comparable to
that observed in peritoneal macrophages ormacrophages gener-
ated from bone marrow or spleen from Atg7MDmice (Figure 1A).uthors
Figure 2. ATG5Deficiency ReducedNeutro-
phil Degranulation
BMN from control or Atg5MD mice were primed
with cytochalasin B and then stimulated with 1 mM
fMLF for 15 or 30 min.
(A and B) Supernatant was collected, incubated for
15 min with tetramethyl-benzidine to determine
levels of MPO (A), or incubated overnight with
p-nitrophenyl-b-D-glucuronide to determine b-D-
glucuronidase (B).
(C) In addition, supernatant was used for immu-
noblotting by lactoferrin antibody. One represen-
tative blot in which each lane corresponds to one
mouse and densitometry analysis is shown.
(D) Gelatinase zymography was performed on
supernatant, and densitometry analysis is shown.
For all panels, each symbol represents onemouse.
n = 6/group. Data are mean ± SEM; *p < 0.05, **p <
0.01.As autophagy has been recently implicated in the secretory
pathway, we hypothesized that autophagy deficiency would
affect neutrophil degranulation. Among the granules origi-
nating from ER-Golgi apparatus, tertiary granules are the first
to release their contents upon activation. To test the effect of
autophagy on degranulation of tertiary granules, we stimu-
lated BMN with cytochalasin B and bacterial tripeptide
fMLF, and used the supernatant for gelatinase zymography.
Loss of ATG7 reduced the levels of MMP-9 secreted after
fMLF treatment (Figure 1B). Gelatinase zymography, per-
formed on the lysates of unstimulated BMN, showed that
baseline levels of MMP-9 in Atg7MD neutrophils were para-
doxically elevated (Figure 1B), suggesting that the reduction
in MMP-9 secretion was due to retention, rather than a defect
in its synthesis.
To determine whether autophagy was involved in the secre-
tion of other types of neutrophil granules, we stimulated
BMN with cytochalasin B and fMLF and evaluated the secre-
tion of b-D-glucuronidase (stored in primary granules) and
lactoferrin (stored in secondary granules). Deficiency of
ATG7 reduced degranulation from both primary and second-
ary granules (Figures 1C and 1D). In contrast, upregulation
of CD11b in response to various stimuli remained unaltered
in Atg7MD neutrophils (Figure 1E). Secretory lysosomes were
also unaffected, as evidenced by similar LAMP-1 levels in
ATG7-deficient and control neutrophils following PMA stimula-
tion (Figure 1F).
To rule out autophagy-independent roles of Atg7 in neutrophil
degranulation, we generated mice with myeloid cell-specific
deletion of Atg5 (Atg5MD mice) (Abdel Fattah et al., 2015). We
found that deletion of Atg5 reduced degranulation of primary,Cell Reports 12, 1731–1739, Sepsecondary, and tertiary granules from
BMNs (Figure 2). These data suggested
that autophagy was required for neutro-
phil degranulation.
We then wanted to determine whether
there was a global dysfunction in auto-
phagy-deficient neutrophils. We have
previously shown that zymosan phago-cytosis was not altered in autophagy-deficient macrophages
(Bonilla et al., 2013). To test whether autophagy deficiency
altered zymosan uptake by neutrophils, we incubated BMN
from control or Atg7MD mice with FITC-labeled zymosan A
and checked phagocytosis by flow cytometry. There was no
significant difference in zymosan A uptake, or surface levels
of CD11b, between control and Atg7MD neutrophils (Figures
S1A and S1B). However, consistent with our previous findings,
we observed substantial reduction of MMP-9 in the super-
natant collected after incubation of zymosan A with Atg7MD
neutrophils (Figure S1C). Thus, the defect in neutrophil degran-
ulation in Atg7MD mice was not part of a global dysfunction in
these cells.
Reduced In Vivo Neutrophil-Mediated Inflammation in
Atg7MD Mice
We hypothesized that autophagy deficiency would reduce
severity of neutrophil-mediated inflammatory diseases in vivo.
To test this hypothesis, we utilized a model of neutrophil-medi-
ated PMA-induced ear inflammation (Gross et al., 2009). Atg7MD
mice showed substantial reduction in ear swelling (Figure 3A).
After PMA application, degranulation of MPO, detectable by
in vivo bioluminescence imaging, requires fusion of primary
granules with phagosomes (Gross et al., 2009). Neutrophil
MPO in Atg7MD mice was substantially reduced (Figure 3B).
These data suggested that autophagy deficiency reduced
degranulation of primary granules by reducing their fusion with
phagosomes.
We then extended our findings to another in vivo model of
inflammation. Intraperitoneal LPS injection increases the perme-
ability of blood-brain barrier, an effect dependent onMMP-9 (Aidtember 22, 2015 ª2015 The Authors 1733
Figure 3. Reduced Neutrophil-Mediated
Inflammation in Atg7MD Mice In Vivo
(A and B) Ear inflammation was induced by topical
application of PMA for 24 hr, and ear thickness
was then measured; n = 7–8/group (A). Biolumi-
nescence imaging was performed. A representa-
tive image and quantitative analysis are shown (B).
Similar symbols denote matched pairs. n = 7/
group.
(C) LPS was injected intra-peritoneally (5 mg/kg, at
0 and 48 hr), and blood-brain barrier permeability
was measured.
(D) BMN were isolated from control and Atg7MD
mice and stimulated with 1 mg/ml LPS for 30 min,
and supernatant was subjected to gelatinase zy-
mography. A representative zymogram, in which
each lane denotes one mouse, and quantitative
analyses are shown. n = 6/group.
(E and F) Peritoneal exudate cells were collected
4 hr after thioglycollate injection. Neutrophils were
isolated and stained with Ly6G (E) and CD11b (F).
(G) Blood was collected by cardiac puncture, and
complete blood count was performed.
(H) BMNwere isolated and counted. For all panels,
each symbol represents one mouse.
Data are mean ± SEM; *p < 0.05, **p < 0.01. MFI,
mean fluorescence intensity.et al., 2010; Bennett et al., 2010). After LPS administration,
we observed that Atg7MD mice showed substantially reduced
permeability of the blood-brain barrier (Figure 3C). Moreover,
MMP-9 release, following stimulation of BMN with LPS, was
also reduced from autophagy-deficient neutrophils (Figure 3D).
These data suggested that autophagy-deficiency reduced over-
all inflammatory potential of neutrophils.
Increased Circulating Neutrophils in Atg7MD Mice
To rule out defects in neutrophil migration, we used a peritonitis
model in which peritoneal exudate cells were collected 4 hr after
intraperitoneal thioglycollate injection. Surprisingly, peritoneal
neutrophils were increased in Atg7MD mice, though no differ-
ences in CD11b levels were observed in these neutrophils (Fig-
ures 3E and 3F). In vitro transwell migration assay showed no
gross defect in Atg7MD neutrophil migration in response to
different stimuli (Figure S1D). Complete blood analysis ofAtg7MD
mice and their littermate controls showed similar total number of
white blood cells (Figure S2), but total and differential neutrophil
counts were higher in the Atg7MD mice (Figures 3G and S2).
The increase in circulating neutrophils in Atg7MD mice was
likely the result of increased neutrophil content in the bone
marrow of Atg7MD mice (Figure 3H). These data suggested that
myeloid-specific autophagy deficiency increased the number
of circulating neutrophils and, consequently, their recruitment
to the site of inflammation. However, because of their reduced
effector functions, these neutrophils could not efficientlymediate
inflammation.1734 Cell Reports 12, 1731–1739, September 22, 2015 ª2015 The AAutophagy Deficiency in Myeloid Cells Reduced
Severity of Experimental Autoimmune
Encephalomyelitis
To further test the inflammatory potential of autophagy-deficient
neutrophils, we used experimental autoimmune encephalomy-
elitis (EAE), an autoimmune model, which mimics several as-
pects of multiple sclerosis disease in humans. Neutrophils
have been implicated as a critical mediator of CNS inflammation
during the effector phase of EAE and neutrophil depletion at
different phases of EAE inhibits or abolishes EAE (McColl et al.,
1998; Rumble et al., 2015; Steinbach et al., 2013). Secretion of
proteases, such asMMP-9, by neutrophils facilitates breakdown
of blood-CNS barrier during EAE (Opdenakker et al., 2001). We
found that, after EAE induction by active immunization, both
control and Atg7MDmice showed 100% incidence of EAE. How-
ever, the severity of EAE was lower in Atg7MD mice (Figure 4A).
Additionally, weight loss and cumulative disease score (area
under the curve) were attenuated in Atg7MD mice (Figures 4B
and 4C).
Consistent with the roles of MMP-9 in breakdown of blood-
CNS barrier, we observed an increase in MMP-9 in spinal cord
lysates, correlating with severity of EAE (Figure S3A). Previous
reports showed that blood-spinal cord barrier, rather than the
blood-brain barrier, was predominantly affected in mouse model
of EAE (Bennett et al., 2010). At the peak of EAE, we observed
reduced amount of Evan’s blue dye in the spinal cord, but not
in organs without permeability barrier, in Atg7MD mice (Figures
4D and S3B). Consistent with attenuation of breakdown ofuthors
Figure 4. Autophagy Deficiency in Myeloid
Cells Reduced Severity of EAE
(A–C) EAE was induced in Atg7MD mice and
littermate controls, and daily clinical scores (A),
daily weight changes (B), and cumulative disease
scores (C) were recorded. n = 12–13/group.
(D) Evaluation of brain and spinal cord barrier
permeability at day 16 after EAE induction.
(E) Mice were sacrificed at day 16 after EAE in-
duction, and CNS-infiltrating cells were isolated by
Percoll gradient.
(F and G) EAE was induced in Atg5MD mice and
littermate controls, and daily clinical scores (F) and
cumulative disease scores (G) were monitored. n =
10–12/group.
(H) Contact hypersensitivity was induced in
Atg7MD and control mice by sensitization and
challenge with Oxazolone (OXA) or DNFB. Ear
swelling wasmeasured 24 hr after challenge. Each
symbol represents one mouse. AUC, area under
the curve.
Data are mean ± SEM; *p < 0.05, **p < 0.01.blood-CNS barrier permeability, we found a significant reduction
in inflammatory cells in the CNS of the Atg7MD mice at the peak
of EAE (Figure 4E).Atg5MDmice also showed a significant reduc-
tion in severity and cumulative disease score of EAE compared
to their littermate controls (Figures 4F and 4G). Six out of ten
Atg5f/f mice reached score 5 compared to one out of 12 Atg5MD
mice (*p = 0.02, chi-square test). Thus, deficiency of either Atg5
or Atg7 in myeloid cells resulted in attenuated EAE phenotype.
Finally, to rule out global immunosuppression in these mice,
we utilized models of hapten-induced contact hypersensitivity
(CHS). CHS is mediated primarily by CD8 T cells (Vocanson
et al., 2009). The severity of hapten-induced CHS in response
to Oxazolone or DNFB remained undiminished in Atg7MD mice
(Figure 4H). Thus, the reduction in severity of EAE in Atg7MD
mice was not due to a global reduction in immune functions.
Peripheral Antigen-Specific T Cell Generation in EAE
Was Unaltered in Atg7MD Mice
To rule out reduced peripheral T cell activation in Atg7MD mice,
we examined MOG-specific T cell proliferation at different
phases of EAE. There was no significant reduction in antigen-
specific T cell proliferation in spleen of Atg7MD mice at any of
the doses or time points tested (Figure S4A). To test whether
macrophage-mediated antigen presentation was defective in
Atg7MD mice, we used DOBW cells, which recognize oval-
bumin323–339 peptide in the context of MHC-II and produce IL-
2 upon proliferation (Harding et al., 1991). We could not detect
any significant differences in antigen presentation between resi-
dent peritoneal macrophages from control and Atg7MD mice
(Figure S4B).Cell Reports 12, 1731–1739, SepWe also ruled out any gross defects in
T cell compartments in Atg7MD mice
that might account for the phenotype
observed (Figures S4C–S4J). Moreover,
we found that use of neutrophil-depleting
1A8 antibody, but not isotype control
antibody, after the onset of EAE abolished the difference be-
tween Atg7f/f and Atg7MD mice in disease severity, cumulative
disease score, and weight loss (Figure S5). Taken together, we
concluded that the protective effect in the Atg7MD mice was
caused by defective neutrophil function and not by changes in
peripheral T cell activation.
Autophagy Deficiency Led to Reduced NADPH Oxidase-
Mediated ROS Production
Flavocytochrome b558, a component of the NADPH oxidase ma-
chinery, is present on the membrane of secondary granules of
neutrophils (Jesaitis et al., 1990). Therefore, NADPH oxidase-
mediated ROS production in neutrophils depends on fusion of
granules with plasma membrane/phagosome. Our in vivo data
suggested a fusion defect between granules and phagosome
as a cause of reduced degranulation. To further examine how
autophagy affectedROSgeneration byNADPHoxidase, we stim-
ulated control or Atg7MD BMNwith fMLF and measured extracel-
lular ROS generation by cytochrome c reduction assay. Atg7MD
neutrophils showed significant reduction in ROS production in
response to fMLF (Figure 5A). Similarly, FcOxyburst assay also re-
vealed reduced phagosomal ROS production by Atg7MD neutro-
phils (Figure 5B). Similar results were found in Atg5MD BMN, in
which both phagosomal ROS generation and extracellular ROS
generation, measured by OxyBURST Green H2 HFF BSA, were
substantially reduced (Figures 5C and 5D). We did not find any
gross difference with respect to fMLF-induced F-actin organiza-
tion between control and Atg7MD neutrophils (data not shown).
Collectively, our data suggested that autophagy deficiency re-
ducedNADPHoxidase-mediatedROSproductionby neutrophils.tember 22, 2015 ª2015 The Authors 1735
Figure 5. Autophagy Deficiency Reduced NADPH Oxidase-Mediated ROS Production in BMN
(A) BMN from control or Atg7MDmice were incubated with cytochrome c and extracellular ROS generation in response to 1 mM fMLF wasmonitored continuously
by measuring changes in absorbance (OD550). Data are from four independent experiments.
(B) BMN from control or Atg7MDmice were incubated with 125 mg/ml FcOxyburst reagent, and phagosomal ROS generation was measured by flow cytometry. A
representative plot and quantitative analyses are shown. Each symbol represents one mouse. Data are from three independent experiments.
(C) BMN from control or Atg5MD mice were incubated with OxyBURST H2HFF Green BSA, and extracellular ROS generation in response to 1 mM fMLF was
monitored bymeasuring changes in fluorescence. Time point 0 is the first time point measured after addition of fMLF. One representative curve for each genotype
and quantitative analyses are shown. n = 4/genotype.
(D) BMN from control or Atg5MDmice were incubated with 125 mg/ml FcOxyburst reagent, and phagosomal ROS generation was measured by flow cytometry. A
representative plot and quantitative analyses are shown. Each symbol represents one mouse. n = 4/genotype.
(E–H) BMN from wild-type mice were pre-treated with DPI (10 mM, 1 hr) and then stimulated with cytochalasin B and fMLF. Supernatant was collected and
b-glucuronidase wasmeasured; n = 8/group. Each pair of symbols represents onemouse (E). Supernatant was also subjected to immunoblotting using lactoferrin
antibody (F) or gelatinase zymography (G). Representative immunoblots and zymogram are shown. (H) Supernatant was analyzed colorimetrically for LDH activity
to detect cell death.
Data are representative of three independent experiments and presented as mean ± SEM; *p < 0.05, **p < 0.01. AUC, area under the curve.We then investigated the effects of NADPH oxidase-mediated
ROS generation on neutrophil degranulation. We pre-treated
BMN from wild-type mice with vehicle only or with diphenyle-
neiodonium chloride (DPI, 10 mM, 1 hr), a specific inhibitor of
NADPH oxidase, and then stimulated these neutrophils with
cytochalasin B and fMLF. Treatment with DPI reduced degranu-
lation of primary, secondary, and tertiary granules and did not
alter cell viability (Figures 5E–5H). Taken together, these data
showed that autophagy deficiency led to reduced NADPH oxi-
dase-mediated ROS production and reduced ROS production
by NADPH oxidase further contributed to reduced degranulation
from Atg7MD neutrophils.
DISCUSSION
Despite extensive characterization of neutrophil phagocytic
activity and granules, the underlying mechanisms governing1736 Cell Reports 12, 1731–1739, September 22, 2015 ª2015 The Afunctions of neutrophils remain incompletely understood. In
this regard, the current study provided several important findings
and established autophagy as a regulator of neutrophil func-
tions. It showed that inhibition of autophagy reduced degranula-
tion from neutrophils. Such reduction was not due to decreased
production of proteins but rather to a secretion defect.Moreover,
deficiency of either Atg5 or Atg7 led to similar defects in de-
granulation from neutrophils, suggesting a role of autophagy,
rather than autophagy-independent ATG functions, in mediating
degranulation from neutrophils. The in vivo relevance of these
findings was confirmed using several mouse models of neutro-
phil-mediated inflammatory and autoimmune processes, which
showed that autophagy deficiency reduced the inflammatory
potential of neutrophils.
Autophagy deficiency produced maximal effects on degran-
ulation of tertiary and secondary granules. In contrast, we
did not find any defect in upregulation of CD11b, suggestinguthors
intact degranulation of secretory vesicles in absence of auto-
phagy. In neutrophils, secretory vesicles degranulate immedi-
ately following mild stimulation. Tertiary and secondary granules
follow secretory vesicles, in that order, and primary granules are
the most difficult to mobilize. It is possible that the differential
effect of autophagy deficiency on different granules is a direct
consequence of ease of mobilizing these granules.
We predominantly used fMLF, which is among the strongest
inducers of neutrophil degranulation. It is possible that fMLF in-
duction masked any potentially small defect in degranulation of
secretory vesicles. However, defective degranulation is unlikely
to be specific for fMLF, as both LPS and zymosan resulted in
reduced MMP-9 release by autophagy-deficient neutrophils.
Thus, our data suggested an intrinsic problem in the degranula-
tion mechanism in absence of autophagy.
Another important finding in this study is the role of NADPHox-
idase and ROS in mediating effects of autophagy on degranula-
tion. Our data are consistent with a recent report, which showed
similar effects of autophagy in mucus secretion by goblet cells
(Patel et al., 2013). However, the potential roles of NADPH oxi-
dase and ROS in mediating neutrophil degranulation remain
incompletely elucidated. Studies by different groups using neu-
trophils isolated from patients of chronic granulomatous dis-
ease, in which NADPH oxidase-mediated ROS generation is
impaired, provided contrasting observations showing impaired,
augmented, or unaltered degranulation (Baehner et al., 1969;
Gold et al., 1974; Pak et al., 2007). Such a wide spectrum of re-
sults could be attributed to demography of patients studied,
types of stimuli used, methods employed, and granular contents
measured as an index of degranulation. Although, in our study,
inhibition of NADPH oxidase resulted in significant reduction
of degranulation, the effects were modest compared to that
observed in autophagy-deficient neutrophils, suggesting that
additional factors contributed to the effect of autophagy on
degranulation.
Assembly of NADPH oxidase requires fusion of secondary
granules, the membrane of which contains b558 subunit, with
phagosomal or plasma membrane (Jesaitis et al., 1990). Auto-
phagy proteins are important for fusion of enzyme-containing
lysosomes with plasma membrane in osteoclasts (DeSelm
et al., 2011). The role of autophagy in mediating granule fusion
is also observed in our study, using in vivo model of PMA-
induced ear inflammation. In this model, bioluminescence im-
aging of neutrophilic MPO by luminol depends on proper fusion
of MPO-containing granules with phagosome (Gross et al.,
2009). We found substantial reduction in MPO bioluminescence
from the PMA-treated ear of Atg7MD mice, suggesting a poten-
tial defect in fusion of these granules with phagosome. Thus,
our study supports a model in which autophagy mediates
both fusion of granules with other membrane compartments
and degranulation. Autophagy-mediated granule fusion helps
in the assembly of an active NADPH oxidase complex and
NADPH oxidase-mediated ROS generation, in turn, further fa-
cilitates degranulation.
Despite normal transwell migration in response to different
stimuli, Atg7MDmice showed increased neutrophils in the perito-
neal cavity following thioglycollate administration. This finding
was likely the result of a higher number of circulating andCell Repbone-marrow neutrophils in Atg7MD mice. We have previously
shown increased proliferative activity of leukocytes in bone
marrow of Atg7MD mice (Abdel Fattah et al., 2015). Moreover,
ROS are critical for several neutrophil death mechanisms
and reduced ROS generation in Atg7MD neutrophils may
also contribute to better survival (Geering and Simon, 2011).
Together, these factors could explain higher numbers of circu-
lating neutrophils in Atg7MD mice.
Emerging evidence suggests that neutrophils play a broad role
in the immune system (Kumar and Sharma, 2010). Neutrophils
have been implicated in autoimmunity and as one of the major
effector cells in EAE (Rumble et al., 2015). Autophagy has also
been implicated in several autoimmune diseases (Bhattacharya
and Eissa, 2013). In this regard, we found that autophagy defi-
ciency in myeloid cells reduced severity of EAE. Reduced
severity of EAE in myeloid-specific autophagy deficient mice
was not due to impairment of peripheral antigen-specific T cell
activation. These results are consistent with our recent findings
supporting dendritic cells (DCs) as a major antigen presenting
cells during EAE (Bhattacharya et al., 2014a). LysMCre-medi-
ated deletion predominantly affects macrophages and neutro-
phils, whereas DCs remain largely unaffected (Clausen et al.,
1999). Normal peripheral T cell activation may reflect unaltered
functions of DCs in these mice. Autophagy-deficient neutrophils
showed reduced secretion of MMP-9, a matrix metalloprotei-
nase involved in breakdown of blood-CNS barrier in EAE.
MMP-9 is considered a potential therapeutic target in multiple
sclerosis and clinical trials with MMP-9 inhibitors are currently
under way (Muroski et al., 2008). Reduced severity of EAE in
Atg7MDmice correlated with reduced permeability of blood-spi-
nal cord barrier and reduced CNS cellular infiltration. Although
our studies utilized well-characterized neutrophil-mediated
in vivo models, they do not exclude possible roles of other
myeloid cells in these models.
In summary, this study revealed an important role of auto-
phagy in neutrophils during inflammatory and autoimmune
diseases. Neutrophils constitute the major portion of circu-
lating leukocytes in humans and are considered the first line
of cellular defense and major inflammatory mediator in the
immune system. Neutrophilic secretion is required not only
during infection but also to maintain normal homeostasis.
Increased neutrophilic secretion has been implicated in the
pathogenesis of diseases such as chronic obstructive lung
disease and cystic fibrosis. Recent studies proposed alter-
ation of the autophagy pathway as a therapeutic approach
to multiple diseases. Our study uncovered autophagy as a
major regulator of neutrophil function and suggested the pos-
sibility that targeting the autophagy pathway might offer an
important approach to treat neutrophil-mediated inflammatory
processes.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 and LysM-Cre transgenic mice in a C57BL/6 background were pur-
chased from Jackson Laboratory. Atg7MD and Atg5MD mice have been previ-
ously described (Bonilla et al., 2013; Shin et al., 2013; Abdel Fattah et al.,
2015). All mice usedwere housed in BCMvivarium (biosafety level 2). All animal
protocols were approved by institutional boards of Baylor College ofMedicine.orts 12, 1731–1739, September 22, 2015 ª2015 The Authors 1737
In Vivo Disease Models
EAE and contact CHS models were induced as described previously (Bhatta-
charya et al., 2014a). For EAE, active immunization was performed with
MOG35–55 peptide emulsified in Freund’s complete adjuvant, along with two
doses of pertussis toxin. Mice were monitored daily for weight changes and
clinical signs (Supplemental Experimental Procedures). CHS was induced by
sensitizing and challenging the mice with Oxazolone or DNFB. Ear thickness
was measured before and 24 hr after the challenge. Acute dermatitis was
induced by applying 20 mg of PMA in 20 ml of DMSO to one ear and DMSO
only (vehicle) to the other ear, and ear swelling wasmeasured after 24 hr. Biolu-
minescence imaging was performed as previously described (Gross et al.,
2009). In brief, mice were anaesthetized by isoflurane and imaging was per-
formed in a Xenogen In Vivo Imaging System (IVIS), 10 min after intraperitoneal
injection of luminol. Quantitation was done by software (Living Image In Vivo
Imaging Software, PerkinElmer).
Isolation of Neutrophils from Bone Marrow or Peritoneal Cavity
Single-cell suspension from bone marrow, after ACK lysis, was subjected to
gradient centrifugation in 60%/80% Percoll, and neutrophils were collected
from the interface (Halpert et al., 2011), washed in HBSS without Ca2+ and
Mg2+, and stained for flow cytometry or used for in vitro stimulation. Peritoneal
lavage was performed with 10ml of ice-cold HBSSwithout Ca2+ andMg2+ 4 hr
after injection of 1 ml thioglycollate, and neutrophils were isolated by Percoll
gradient.
BMN Stimulation and Assessing Degranulation
Isolated BMN were allowed to settle for 20–30 min at 37C, 5% CO2 and then
pre-treated for 5 min with 10 mg/ml of cytochalasin B. BMN were then stimu-
lated with 1 mM fMLF, 1 mg/ml of LPS or PMA, or 10 ng/ml of GM-CSF for
various time points. In some experiments, neutrophils were pre-treated for
2 hr with 50 mM CQ and then cytochalasin B was added for 5 min, followed
by fMLF stimulation. Supernatant was collected by centrifugation and cells
were prepared for flow cytometry. MMP-9 zymography was performed using
Novex 10% Zymogram (Gelatin) Gel. For MPO detection, supernatant was
incubated with TMB reaction mixture (1 mg of 3,30,5,50-tetramethylbenzidine
in 1 ml of DMSO and 9 ml of 0.1 M NaH2PO4 (pH 5.5) with 2 ml of fresh 30%
hydrogen peroxide) for 15min (in dark) and OD615 was measured immediately.
For detection of b-glucuronidase, supernatant was incubated overnight with
3.15 mg/ml p-nitrophenyl-itroglucuronide in 0.17 M sodium acetate buffer
(pH 4.0), reaction was terminated by adding 0.4 M glycine (pH 10), and
OD405 was measured immediately.
Measurement of ROS Production
Cytochrome c reduction assay and OxyBURST Green H2HFF BSA assay
were performed to detect extracellular ROS production using 0.5 3 106 to 1 3
106 cells/well or 2 3 106 cells/well, respectively in a 96-well plate. Cytochrome
c or OxyBURST Green H2HFF BSA was added (final concentration of
1.5 mg/ml or 10 mg/ml, respectively) to the cells and baseline absorbance/fluo-
rescence was recorded. fMLF was then added (final concentration: 1 mM in
200 ml/well) and absorbance/fluorescence was monitored continuously at
550 nm (absorbance) or at 488 nm excitation and 530 nm emission (fluores-
cence). FcOxyburst assays were performed according to the manufacturer’s
instructions (Invitrogen). In brief, flow cytometric measurement was performed
using a total of 2 3 106 cells/tube. After baseline reading, FcOxyburst reagent
wasadded (125mg/ml in a final volumeof400ml), anddatawerecollectedcontin-
uously with LSR Fortessa (Becton Dickinson). FACSDiva software was used for
data collection, and FlowJo software was used for analysis. Cell viability assays
were performed using lactate dehydrogenase (LDH) detection kit (Roche).
Statistical Analysis
Normally distributed data were analyzed by Student’s t test (Welch correction
was applied in case of significant difference in variance between the groups),
and non-parametric comparisons were performed by Mann-Whitney test. For
EAE data, curves were compared by ANOVA, daily clinical scores and weight
changes by Student’s t test. Paired t test was used for comparisons between
matched pairs (in vivo bioluminescence and degranulation of primary granules
after DPI treatment). Analyses were performed by GraphPad Prism 6.1738 Cell Reports 12, 1731–1739, September 22, 2015 ª2015 The ASUPPLEMENTAL INFORMATION
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